Improving care for @entity1 with XXXX .

@entity1 @entity3458 @entity5837
BACKGROUND: @entity5837 ( @entity5837 ) is a leading cause of hospitalization and death of @entity1 with @entity3458 ( @entity3458 ). An evidence-based @entity5837 / @entity3458 guideline was established to standardize care throughout the institution in February 2008. However, by the summer of 2009 use of the guideline was inconsistent, and did not seem to have an impact on length of stay. As a result, an implementation program was developed. OBJECTIVE: This quality-improvement project evaluated the influence of the development and implementation of a clinical practice guideline for @entity1 with @entity3458 with @entity5837 or at risk for @entity5837 on clinical outcomes. METHODS: Clinical outcomes of 139 @entity1 with @entity3458 were evaluated before and after the development of the implementation program. Outcomes included average length of stay, number of exchange transfusions, average cost per @entity3458 admission, and documentation of the clinical respiratory score and pulmonary interventions. RESULTS: Average length of stay decreased from 5.8 days before implementation of the guideline to 4.1 days after implementation (P = .033). No @entity1 required an exchange transfusion. Average cost per @entity3458 admission decreased from  30 359 before guideline implementation to  22 368. Documentation of the clinical respiratory score increased from 31.0% before implementation to 75.5%, which is an improvement of 44.5% (P < .001). Documentation of incentive spirometry and positive expiratory pressure increased from 23.3% before implementation to 50.4%, which is an improvement of 27.1% (P < .001). CONCLUSIONS: Implementation of a guideline for @entity1 with @entity3458 with @entity5837 or at risk for @entity5837 improved outcomes for @entity1 with @entity3458 .
